Analysts who follow Atara Biotherapeutics Inc (ATRA) on average expect it to climb 454.93% over the next twelve months. Those same analysts give the stock an average rating of Hold. That average rating earns Atara Biotherapeutics Inc an Analyst Ranking of 5, which means it ranks higher than 5 of stocks, based on data compiled by InvestorsObserver.
Wall Street analysts are rating ATRA a Hold today. Find out what this means to you and get the rest of the rankings on ATRA!